Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| CEO | Houston John G | 1.16M | $15.31M | - |
| Other | Berkowitz Noah | 169.6K | $2.23M | - |
| CFO | Saik Andrew | 164.4K | $2.17M | - |
| Pres | Taylor Ian | 160.8K | $2.12M | - |
| Other | Cacace Angela M | 154.2K | $2.03M | - |
Transactions
50 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2025-11-07 | Loomis David K | Chief Accounting Officer | Sell | 230 | $9.89 | $2,274.70 | -0.7% | → |
| 2025-09-22 | Morrison Briggs | Director | Buy | 30,000 | $7.57 | $227,010.00 | +65.2% | → |
| 2025-06-24 | Saik Andrew | Chief Financial Officer | Sell | 5,700 | $7.61 | $43,377.00 | -3.4% | → |
| 2025-06-17 | Cacace Angela M | Chief Scientific Officer | Sell | 2,583 | $7.49 | $19,346.67 | -1.6% | → |
| 2025-03-18 | Berkowitz Noah | Chief Medical Officer | Sell | 8,658 | $8.59 | $74,372.22 | -7.3% | → |
| 2025-02-24 | Loomis David K | Chief Accounting Officer | Sell | 1,214 | $16.75 | $20,334.50 | -6.0% | → |
| 2025-02-24 | Houston John G | President and CEO | Sell | 31,338 | $16.72 | $523,880.70 | -1.3% | → |
| 2025-02-24 | Cacace Angela M | Chief Scientific Officer | Sell | 4,207 | $16.70 | $70,238.05 | -2.1% | → |
| 2025-02-24 | Taylor Ian | President, R&D | Sell | 9,020 | $16.71 | $150,752.20 | -2.7% | → |
| 2024-11-07 | Loomis David K | Chief Accounting Officer | Sell | 460 | $22.39 | $10,300.84 | -2.7% | → |
| 2024-02-23 | Cassidy Sean A | Chief Financial Officer | Sell | 1,702 | $47.05 | $80,079.10 | -0.9% | → |
| 2024-02-23 | Peck Ronald | Chief Medical Officer | Sell | 1,699 | $47.05 | $79,937.95 | -2.5% | → |
| 2024-02-23 | Taylor Ian | Chief Scientific Officer | Sell | 1,701 | $47.05 | $80,032.05 | -1.1% | → |
| 2024-02-23 | Houston John G | President and CEO | Sell | 5,196 | $47.05 | $244,471.80 | -0.5% | → |
| 2023-08-11 | Peck Ronald | Chief Medical Officer | Sale+OE | 1,324 | $24.39 | $32,288.52 | -4.2% | → |
| 2023-03-01 | Cassidy Sean A | Chief Financial Officer | Sale+OE | 1,745 | $29.53 | $51,529.85 | -0.9% | → |
| 2023-03-01 | Houston John G | President and CEO | Sale+OE | 5,878 | $29.53 | $173,577.34 | -0.6% | → |
| 2023-03-01 | Taylor Ian | Chief Scientific Officer | Sale+OE | 1,051 | $29.53 | $31,036.03 | -1.0% | → |
| 2022-08-12 | Peck Ronald | Chief Medical Officer | Sale+OE | 1,258 | $68.99 | $86,794.45 | -13.4% | → |
| 2022-04-14 | Morrison Briggs | Director | Sale+OE | 20,960 | $66.44 | $1,392,615.84 | -19.1% | → |
| 2022-03-11 | Cassidy Sean A | Chief Financial Officer | Sale+OE | 15,000 | $70.00 | $1,050,000.00 | -8.5% | → |
| 2022-03-04 | Houston John G | President and CEO | Sale+OE | 6,024 | $63.94 | $385,174.56 | -0.7% | → |
| 2022-03-04 | Cassidy Sean A | Chief Financial Officer | Sale+OE | 1,593 | $63.94 | $101,856.42 | -1.0% | → |
| 2022-03-04 | Taylor Ian | Chief Scientific Officer | Sale+OE | 869 | $63.94 | $55,563.86 | -1.0% | → |
| 2022-02-15 | Taylor Ian | Chief Scientific Officer | Sale+OE | 20,000 | $73.02 | $1,460,315.80 | -3.9% | → |
| 2022-01-14 | Morrison Briggs | Director | Sale+OE | 20,960 | $65.55 | $1,374,020.57 | -14.9% | → |
| 2021-12-30 | Peck Ronald | Chief Medical Officer | Sale+OE | 20,000 | $80.61 | $1,612,263.69 | -50.7% | → |
| 2021-12-17 | Cassidy Sean A | Chief Financial Officer | Sale+OE | 15,000 | $70.00 | $1,050,000.00 | -8.7% | → |
| 2021-12-16 | Ratcliffe Liam | Director | Sell | 319,397 | $67.19 | $21,459,422.04 | -13.2% | → |